ASCO 2019: First-line pembrolizumab for advanced kidney cancer
Two presentations on the results of the KEYNOTE-427 clinical trial [...]
ASCO 2019: Treatment of sarcomatoid kidney cancer
The following presentation from the American Society of Clinical Oncology [...]
ASCO 2019: Immunotherapy before surgery for treating metastatic kidney cancer
The results of this open-label pilot study were presented at [...]
ASCO 2019: First-line immunotherapy combinations in metastatic kidney cancer
This presentation from the American Society of Clinical Oncology (ASCO) [...]
ASCO 2019: Active surveillance in metastatic kidney cancer
This study used data from the Canadian Kidney Cancer Information [...]
ASCO 2019: Analysis of CARMENA trial results using IMDC risk groups
The results from CARMENA, a randomised phase III clinical trial [...]
ASCO 2019: Biomarkers for advanced renal cell carcinoma from the JAVELIN Renal 101 study
Results from the biomarker analysis from the JAVALIN Renal 101 [...]
Atezolizumab plus bevacizumab combination for untreated metastatic kidney cancer
Results from this phase III trial of atezolizumab plus bevacizumab [...]
A review of adjuvant therapy options for kidney cancer
In this paper, published in Current Treatment Options in Oncology [...]
Biomarkers for kidney cancer
This interview from Practice Update with Dr Neeraj Agarwal from [...]
